Bringing the fundamentals into focus…
Back to Cytek Biosciences, Inc.
How Cytek Biosciences, Inc. stacks up
CTKB · against 437 other Healthcare companies of similar size
Growth
34/ 100
Below the middle of the pack.
Ranked #257 of 438 · scores higher than 40% of peers
Bars: peers in each 10-point band of the growth score49 peers with a growth score of 30–39, including CTKB · Click a bar to see the companies
Why growth scores 34?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings per share growth, which is weaker than most Healthcare peers.
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- Revenue growth is close to the peer norm. Revenue growth: 5.4% vs peer median 6.1%
- 3-year revenue growth is close to the peer norm. 3-year revenue growth: 5.6% vs peer median 5.8%
Metric by metric
Position: dot = CTKB, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CTKB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 449 reported | 5.4% | 3.7% | 56% | 33% | |
| Earnings per share growthHigher is better · 242 reported | Not reported | 5.5% | — | — | 33% |
| 3-year revenue growthHigher is better · 431 reported | 5.6% | 4.6% | 54% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around CTKB| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 257 | 798.5B KRW (≈$575M) | 34 | 54 | |
| 257 | 10.2B CNY (≈$1.4B) | 34 | 55 | |
| 257 | 5.3B CNY (≈$743M) | 34 | 65 | |
| 257 | 5.4B CNY (≈$751M) | 34 | 71 | |
| 257 | 775M USD | 34 | 31 | |
| 257 | 56.1B INR (≈$673M) | 34 | 49 | |
| 264 | 15.8B TWD (≈$490M) | 33 | 64 | |
| 264 | 3.4B SAR (≈$909M) | 33 | 62 | |
| 264 | 14.9B TWD (≈$462M) | 33 | 42 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score